HDAC9 and neoplasm: HDAC inhibitors have been firstly developed in oncology as anti-cancer drugs, because of the frequent overexpression of HDACs in several tumor types, however, it is important to underline that HDAC inhibitors can have a direct effect on immune cells themselves.